Study of Eye Biomarkers in Adults With Chorioretinal Diseases Including Diabetic Retinopathy and Macular Degeneration

What this Trial Is About

Researchers are studying patients with various chorioretinal diseases such as diabetic retinopathy, retinal vascular diseases, age-related macular degeneration both dry and wet types, and retinal degeneration. The goal is to investigate levels of ocular biomarkers in these patients compared to control patients without diabetic retinopathy undergoing cataract or other eye surgeries. This observational study aims to better understand biomarker changes related to these eye conditions. The study includes two groups patients with chorioretinal diseases and control patients who are undergoing surgeries like cataract removal or vitrectomy for other eye issues. Before treatment with anti-vascular endothelial growth factor agents or other retinal surgeries, ocular fluid and blood samples are collected from participants. These samples are then analyzed to measure ocular biomarkers. Participants will have samples taken before their eye treatments and will be monitored for biomarker levels, with a primary outcome measured one month after sampling. The study involves 50 patients in each group, with assessments including ocular fluid and blood sample analysis. Participation involves routine ophthalmologic evaluations and sample collections. The overall study duration spans from initial sample collection to biomarker analysis at one month post-procedure.

Analysis of Biomarkers From Patients With Chorioretinal Diseases